AI startup Cursor has raised $2.3 billion in a funding round, bringing its valuation to $29.3 billion. The company is known for its AI coding tool, which launched in 2023. "Our immediate focus is on building out the company and growing the team, and we have a lot more to do there before thinking about anything like going public," said Cursor CEO Michael Truell.

AI startup Thinking Machines, founded by former OpenAI executive Mira Murati, is reportedly in talks to raise funding at a $50 billion valuation. The company has already raised $2 billion at a $12 billion valuation in a seed round, and it subsequently released a product for customizing large language models.

Forterra has raised $238 million in a Series C funding round, bringing its total funds raised to $411 million. The company focuses on autonomous mission systems for defense.

Harbinger has raised $160 million in Series C funding, led by FedEx and Thor Industries, to scale production of its electric truck chassis. FedEx has ordered 53 chassis for delivery by the end of the year.

AI startup Parallel Web Systems has raised $100 million in a Series A round, valuing the company at $740 million. Parallel aims to create web search infrastructure for AI agents, allowing them to access up-to-date information from the web. The company plans to use the funds for product development and customer acquisition.

Endolith, a Denver-based biotech startup, has raised $13.5 million in Series A funding, aiming to extract critical minerals from low-grade ore using AI and microbes. The funding comes as the US and its allies seek to strengthen supply chains for minerals essential for electric vehicles and other technologies.

The US venture secondary market has reached $94.9 billion in annual value, driven by rising valuations and liquidity pressures.

Stockholm-based AI coding startup Lovable is reportedly raising funds at a $6 billion valuation, significantly up from its $1.8 billion valuation in July.

OpenAI is investing in Red Queen Bio, a startup focused on preventing the creation of AI-powered biological weapons. Red Queen Bio, spun out of Helix Nano, will use AI and traditional lab methods to identify and mitigate bio risks.